ATE470858T1 - Opiatrezeptoren - Google Patents

Opiatrezeptoren

Info

Publication number
ATE470858T1
ATE470858T1 AT02731098T AT02731098T ATE470858T1 AT E470858 T1 ATE470858 T1 AT E470858T1 AT 02731098 T AT02731098 T AT 02731098T AT 02731098 T AT02731098 T AT 02731098T AT E470858 T1 ATE470858 T1 AT E470858T1
Authority
AT
Austria
Prior art keywords
nucleic acid
isolated nucleic
opiate receptor
receptor activity
opiator
Prior art date
Application number
AT02731098T
Other languages
English (en)
Inventor
Patrick Cadet
George Stefano
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE470858T1 publication Critical patent/ATE470858T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90245—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02731098T 2001-02-22 2002-02-22 Opiatrezeptoren ATE470858T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27047901P 2001-02-22 2001-02-22
US33667701P 2001-12-05 2001-12-05
PCT/US2002/005452 WO2002068594A2 (en) 2001-02-22 2002-02-22 Opiate receptors

Publications (1)

Publication Number Publication Date
ATE470858T1 true ATE470858T1 (de) 2010-06-15

Family

ID=26954322

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02731098T ATE470858T1 (de) 2001-02-22 2002-02-22 Opiatrezeptoren

Country Status (7)

Country Link
US (3) US7094892B2 (de)
EP (1) EP1377826B1 (de)
AT (1) ATE470858T1 (de)
AU (1) AU2002303098A1 (de)
CA (1) CA2439175C (de)
DE (1) DE60236643D1 (de)
WO (1) WO2002068594A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005259235A1 (en) * 2004-06-25 2006-01-12 Janssen Pharmaceutica N.V. Functional screening assay
US8394664B2 (en) * 2006-02-02 2013-03-12 William Marsh Rice University Electrical device fabrication from nanotube formations
WO2016176458A1 (en) * 2015-04-28 2016-11-03 Proove Biosciences, Inc. System and method for processing genotype information relating to opiod risk

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5341204A (en) * 1993-06-29 1994-08-23 Grant Engineering, Inc. Shearing optical element for interferometric analysis system
CA2196200A1 (en) * 1994-07-29 1996-02-15 Michael Joseph Browne Novel compounds
WO1997008321A1 (en) * 1995-08-24 1997-03-06 Magainin Pharmaceuticals Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
WO1999024471A1 (en) 1997-11-10 1999-05-20 The Research Foundation Of State University Of New York Opiate, cannabinoid, and estrogen receptors
WO2000004046A2 (en) * 1998-07-16 2000-01-27 Memorial Sloan-Kettering Cancer Center Multiple splice variants of the mu-opioid receptor gene
FI982796A7 (fi) 1998-12-23 2000-06-24 Nokia Corp Tiedonsiirron tehostaminen

Also Published As

Publication number Publication date
WO2002068594A3 (en) 2003-05-30
EP1377826A4 (de) 2006-11-29
US20060229444A1 (en) 2006-10-12
DE60236643D1 (de) 2010-07-22
CA2439175A1 (en) 2002-09-06
US20030054451A1 (en) 2003-03-20
WO2002068594A2 (en) 2002-09-06
US20080182316A1 (en) 2008-07-31
US7094892B2 (en) 2006-08-22
AU2002303098A1 (en) 2002-09-12
US7285655B2 (en) 2007-10-23
CA2439175C (en) 2014-05-06
EP1377826B1 (de) 2010-06-09
US7671176B2 (en) 2010-03-02
EP1377826A2 (de) 2004-01-07

Similar Documents

Publication Publication Date Title
SG158736A1 (en) Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
NO20011513L (no) Reseptor-baserte antagonister samt fremgangsmåte ved fremstilling og anvendelse derav
EA200500330A1 (ru) Антагонисты nogo рецепторов
GEP20094629B (en) Nogo receptor binding protein
WO1999000410A3 (en) Human extracellular matrix proteins
EP1589106A4 (de) Adiponektin-rezeptor und dafür kodierendes gen
BRPI0413426A (pt) antagonistas de receptor novo
WO2000015793A3 (en) Human gpcr proteins
WO2003027228A3 (en) Receptors and membrane-associated proteins
WO2003002604A3 (en) G protein coupled receptors and dna sequences thereof
EP1292678B8 (de) G-protein gekoppelte rezeptoren
WO2003018798A3 (en) G-protein coupled receptor and dna sequences thereof
WO2001005970A3 (en) Gtp-binding protein associated factors
WO2001007612A3 (en) Receptors and associated proteins
DK1363944T3 (da) Höjaffinitetsantagonister for ELR-CXC-kemokiner
WO1999024587A3 (en) Human phospholipase a2 protein and dna encoding it
DE60236643D1 (de) Opiatrezeptoren
WO2000020590A3 (en) G-protein coupled receptor proteins
WO2003070902A3 (en) Receptors and membrane-associated proteins
WO2002094990A3 (en) Receptors and membrane-associated proteins
WO2003044162A3 (en) Genes encoding g-protein coupled receptors and methods of use therefor
WO2001042285A3 (en) Extracellular matrix and cell adhesion proteins as well as genes encoding them
WO2002063004A3 (en) G-protein coupled receptors
DE69930873D1 (de) Dna-moleküle kodierende spleissvarianten des humanen melanocortin-1-rezeptorproteins
ATE443083T1 (de) Kationenleitende gaba-a-rezeptoren und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties